Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Cupriavidus taiwanensis NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP453618DZS
CSB-EP453618DZS
CSB-BP453618DZS
CSB-MP453618DZS
CSB-EP453618DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Co-chaperone protein hscB homolog (hscB) CSB-YP453619DZS
CSB-EP453619DZS
CSB-BP453619DZS
CSB-MP453619DZS
CSB-EP453619DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Cysteine--tRNA ligase (cysS) CSB-YP453620DZS
CSB-EP453620DZS
CSB-BP453620DZS
CSB-MP453620DZS
CSB-EP453620DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (ispF) CSB-YP453621DZS
CSB-EP453621DZS
CSB-BP453621DZS
CSB-MP453621DZS
CSB-EP453621DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Pyridoxine/pyridoxamine 5'-phosphate oxidase (pdxH) CSB-YP453622DZS
CSB-EP453622DZS
CSB-BP453622DZS
CSB-MP453622DZS
CSB-EP453622DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Aspartate carbamoyltransferase (pyrB) CSB-YP453623DZS
CSB-EP453623DZS
CSB-BP453623DZS
CSB-MP453623DZS
CSB-EP453623DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis ATP-dependent Clp protease adapter protein ClpS (clpS) CSB-YP453624DZS
CSB-EP453624DZS
CSB-BP453624DZS
CSB-MP453624DZS
CSB-EP453624DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis UPF0758 protein RALTA_A2508 (RALTA_A2508) CSB-YP453625DZS
CSB-EP453625DZS
CSB-BP453625DZS
CSB-MP453625DZS
CSB-EP453625DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Aspartate 1-decarboxylase (panD) CSB-YP453626DZS
CSB-EP453626DZS
CSB-BP453626DZS
CSB-MP453626DZS
CSB-EP453626DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP453627DZS
CSB-EP453627DZS
CSB-BP453627DZS
CSB-MP453627DZS
CSB-EP453627DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP453628DZS
CSB-EP453628DZS
CSB-BP453628DZS
CSB-MP453628DZS
CSB-EP453628DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Probable GTP-binding protein EngB (engB) CSB-YP453629DZS
CSB-EP453629DZS
CSB-BP453629DZS
CSB-MP453629DZS
CSB-EP453629DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis 50S ribosomal protein L30 (rpmD) CSB-YP453630DZS
CSB-EP453630DZS
CSB-BP453630DZS
CSB-MP453630DZS
CSB-EP453630DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis 50S ribosomal protein L16 (rplP) CSB-YP453631DZS
CSB-EP453631DZS
CSB-BP453631DZS
CSB-MP453631DZS
CSB-EP453631DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis 30S ribosomal protein S12 (rpsL) CSB-YP453632DZS
CSB-EP453632DZS
CSB-BP453632DZS
CSB-MP453632DZS
CSB-EP453632DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Proline--tRNA ligase (proS) CSB-YP453633DZS
CSB-EP453633DZS
CSB-BP453633DZS
CSB-MP453633DZS
CSB-EP453633DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Coenzyme PQQ synthesis protein B (pqqB) CSB-YP453634DZS
CSB-EP453634DZS
CSB-BP453634DZS
CSB-MP453634DZS
CSB-EP453634DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus taiwanensis Flagellar brake protein YcgR (ycgR) CSB-YP453635DZS
CSB-EP453635DZS
CSB-BP453635DZS
CSB-MP453635DZS
CSB-EP453635DZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein HRI1 (HRI1) CSB-YP453636SVP
CSB-EP453636SVP
CSB-BP453636SVP
CSB-MP453636SVP
CSB-EP453636SVP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Autophagy-related protein 33 (ATG33), partial CSB-YP453637SVP1
CSB-EP453637SVP1
CSB-BP453637SVP1
CSB-MP453637SVP1
CSB-EP453637SVP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>